Atlas Trials

Stage III Pancreatic Cancer AJCC v6 and v7

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage III Pancreatic Cancer AJCC v6 and v7

RecordFirmDate
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer (NCT03257761)University of Southern California2018-02-07
Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R Mutations (NCT03040986)National Cancer Institute (NCI)2017-07-21
Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer (NCT03073785)University of Nebraska2016-09-16
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors (NCT02498613)National Cancer Institute (NCI)2016-08-31
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy (NCT02381561)National Cancer Institute (NCI)2016-02-01
Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery (NCT02336087)City of Hope Medical Center2016-01-14
Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer (NCT02394535)M.D. Anderson Cancer Center2015-11-12
Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer (NCT02451553)University of Washington2015-11-05
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT02194829)National Cancer Institute (NCI)2014-08-19
Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery (NCT01783171)National Cancer Institute (NCI)2013-01-15
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction (NCT01638533)National Cancer Institute (NCI)2012-08-03
Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT01660971)National Cancer Institute (NCI)2012-07-30
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery (NCT00669734)National Cancer Institute (NCI)2010-02-01
3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery (NCT00288093)National Cancer Institute (NCI)2006-12-20

Track Stage III Pancreatic Cancer AJCC v6 and v7 automatically

Every clearance here is in the API, with alerts when new ones post.